Literature DB >> 24846940

[Expression profiling and functional analysis of hsa-miR-125b and its target genes in drug-resistant cell line of human gastric cancer].

Yan Cheng1, Lin Chen2, Xin Cao3, Siqimeige Ha3, Xiaodong Xie4.   

Abstract

The expression of hsa-miR-125b is significantly downregulated in the fluorouracil-resistant cell line of human gastric cancer (BGC823/Fu). In order to investigate the role of hsa-miR-125b in the drug-resistance acquisition process of human gastric cancer, we performed a series of analysis on the sequence characteristics, species conservation, target genes, function annotation and signal transduction pathway enrichment of hsa-miR-125b using a combined bioinformatic approach such as miRbase, TargetScan6.2, PicTar, miRanda, Gene Ontology(GO) and KEGG. The results showed that the sequence of miR-125b is highly conserved in multiple species. A total of 79 target genes related to transcription regulation, protein binding, enzyme activity (P<0.001) were predicted by bioinformatics software. These genes involved in many biological processes including cell cycle, cell proliferation, cell apoptosis and cell responses to cytokine, drug responses and DNA damage (P<0.001). And these target genes mainly belong to MAPK, Wnt and p53 signal transduction pathways (P<0.01). The results revealed that hsa-miR-125b may regulate multiple biological processes and signal transduction pathways, and drug-resistant occurrence is associated with cell proliferation, cell apoptosis, cell cycle and signaling pathways including MAPK, Wnt and p53. We suggest that hsa-miR-125b may affect chemosensitivity by regulating target genes involved in the above processes and these target genes might be reliable candidates for exploring the role of hsa-miR-125b in tumor chemoresistance.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24846940     DOI: 10.3724/sp.j.1005.2014.00119

Source DB:  PubMed          Journal:  Yi Chuan        ISSN: 0253-9772


  3 in total

1.  miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway.

Authors:  Ismael Riquelme; Oscar Tapia; Pamela Leal; Alejandra Sandoval; Matthew G Varga; Pablo Letelier; Kurt Buchegger; Carolina Bizama; Jaime A Espinoza; Richard M Peek; Juan Carlos Araya; Juan Carlos Roa
Journal:  Cell Oncol (Dordr)       Date:  2015-10-12       Impact factor: 6.730

Review 2.  Emerging Role of miRNAs in the Drug Resistance of Gastric Cancer.

Authors:  Ismael Riquelme; Pablo Letelier; Angela L Riffo-Campos; Priscilla Brebi; Juan Carlos Roa
Journal:  Int J Mol Sci       Date:  2016-03-22       Impact factor: 5.923

3.  Downregulation of miR‑486‑5p in papillary thyroid carcinoma tissue: A study based on microarray and miRNA sequencing.

Authors:  Dong-Yue Wen; Deng-Hua Pan; Peng Lin; Qiu-Yan Mo; Yun-Peng Wei; Yi-Huan Luo; Gang Chen; Yun He; Jun-Qiang Chen; Hong Yang
Journal:  Mol Med Rep       Date:  2018-07-03       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.